ClinicalTrials.Veeva

Menu

Non-contrast Abbreviated MRI for Secondary Surveillance of HCC

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Hepatocellular Carcinoma

Treatments

Diagnostic Test: Contrast enhanced liver CT
Diagnostic Test: non-contrast abbreviated MRI

Study type

Observational

Funder types

Other

Identifiers

NCT05690451
KCT0006395 (Registry Identifier)
H-2106-183-1230

Details and patient eligibility

About

This prospective multicenter study aimed to compare the diagnostic performance of non-contrast abbreviated MRI in detecting recurrent HCC after curative treatment to that of contrast-enhanced liver CT.

Full description

This study was designed as a prospective single-arm intra-individual comparison multicenter study

Enrollment

210 patients

Sex

All

Ages

20 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 20-year old and 85-year old
  • Patients with a history of curative treatment for HCC including surgical resection or local ablation
  • No recurrence after curative treatment of HCC for more than two years
  • Patient who has the plan to perform contrast-enhanced liver CT for secondary surveillance for HCC (i.e., to detect de novo or recurrent HCC)

Exclusion criteria

  • Estimated GFR less than 60
  • Previous history of severe allergic reaction to the iodinated contrast agent
  • Patients with claustrophobia who can't undergo MR examination
  • Patients having cochlear implants or cardiac pacemaker

Trial contacts and locations

3

Loading...

Central trial contact

Dong Ho Lee, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems